- Untargeted Metabolomics
- Lipidomics
- Targeted Metabolomics
- Functional Metabolomics
-
Proteomics
- Nanoparticle proteomics
- iTRAQ/TMT-based Proteomics Analysis
- Label free Quantitative Proteomics
- Protein Identification
- DIA proteomics
- Peptidomics
- Parallel Reaction Monitoring (PRM) Targeted Proteome
- Metpro -Ⅱ Protein-Metabolite Interactions
- Phosphoproteomics
- Acetylation Analysis
- Protein Ubiquitination Analysis
Primarily produced by anaerobic bacteria in the colon through the fermentation of dietary fibers and indigestible sugars, the types and amounts of short-chain fatty acids generated in the intestines vary based on fermentation substrates, bacterial species, and other factors. As crucial metabolic byproducts of intestinal microbiota, SCFAs play diverse biological roles, such as providing energy, regulating energy metabolism, participating in signal transduction, improving cardiovascular health, alleviating symptoms of diabetes, maintaining intestinal metabolic integrity, and modulating gut microbiota and immune function.
In plants, short-chain fatty acids serve as essential flavor compounds and nutritional substances. They play a significant role in the aroma of tobacco. In animals, these acids can increase the feed intake of pregnant sows and milk production in lactating sows, thereby enhancing overall productivity. In silage, acetic acid and propionic acid are primarily used as preservatives for storage and preservation, affecting the palatability and digestibility of the feed.
Technical Advantages:
Application Areas:
- Development research of drugs or health products
- Discovery research of early diagnostic markers for diseases
- Flavor research in plants
- Addition to livestock and poultry feed
Collaboration Cases:
- "Coprococcus eutactus, a Potent Probiotic, Alleviates Colitis via Acetate-Mediated IgA Response and Microbiota Restoration," 2023, Journal of Agricultural and Food Chemistry (IF=5.895)【Customer Article】
- "Polyphenols from foxtail millet bran ameliorate DSS-induced colitis by remodeling gut microbiome," 2023, Frontiers in Nutrition (IF=6.59)【Customer Article】
- "Effects of compound prebiotics as prophylactic and therapeutic supplementation in a mouse model of acute colitis," 2022, Applied Microbiology and Biotechnology (IF=5.56)【Customer Article】
